UT
Utah House Bill HB0123

Utah 2025 Regular Session

Utah House Bill HB0123 Compare Versions

OldNewDifferences
1-01-23 11:03 1st Sub. (Buff) H.B. 123
2-Jennifer Dailey-Provost proposes the following substitute bill:
1+01-07 15:45 H.B. 123
32 1
43 Pharmacy Accessibility Amendments
54 2025 GENERAL SESSION
65 STATE OF UTAH
76 Chief Sponsor: Jennifer Dailey-Provost
87 2
98
109 3
1110 LONG TITLE
1211 4
1312 General Description:
1413 5
1514 This bill addresses prescription drug labeling.
1615 6
1716 Highlighted Provisions:
1817 7
1918 This bill:
2019 8
2120 ▸ makes technical and conforming changes; and
2221 9
2322 ▸ requires a pharmacy to use an accessible prescription label for prescriptions dispensed to
2423 10
2524 a patient who identifies as visually impaired and requests an accessible prescription label.
2625 11
2726 Money Appropriated in this Bill:
2827 12
2928 None
3029 13
3130 Other Special Clauses:
3231 14
33-This bill provides a special effective date.
32+None
3433 15
3534 Utah Code Sections Affected:
3635 16
3736 AMENDS:
3837 17
3938 58-17b-602, as last amended by Laws of Utah 2023, Chapter 328
4039 18
4140
4241 19
4342 Be it enacted by the Legislature of the state of Utah:
4443 20
4544 Section 1. Section 58-17b-602 is amended to read:
4645 21
4746 58-17b-602 . Prescription orders -- Information required -- Alteration -- Labels --
4847 22
4948 Signatures -- Dispensing in pharmacies.
5049 23
5150 (1) Except as provided in Section 58-1-501.3, the minimum information that shall be
5251 24
5352 included in a prescription order, and that may be defined by rule, is:
5453 25
5554 (a) the prescriber's name, address, and telephone number, and, if the order is for a
5655 26
5756 controlled substance, the patient's age and the prescriber's DEA number;
5857 27
5958 (b) the patient's name and address or, in the case of an animal, the name of the owner
6059 28
6160 and species of the animal;
6261 29
6362 (c) the date of issuance;
6463 30
65-(d) the name of the medication or device prescribed and dispensing instructions, if 1st Sub. (Buff) H.B. 123 01-23 11:03
64+(d) the name of the medication or device prescribed and dispensing instructions, if
6665 31
67-necessary;
66+necessary; H.B. 123 01-07 15:45
6867 32
6968 (e) the directions, if appropriate, for the use of the prescription by the patient or animal
7069 33
7170 and any refill, special labeling, or other instructions;
7271 34
7372 (f) the prescriber's signature if the prescription order is written;
7473 35
7574 (g) if the order is an electronically transmitted prescription order, the prescribing
7675 36
7776 practitioner's electronic signature; and
7877 37
7978 (h) if the order is a hard copy prescription order generated from electronic media, the
8079 38
8180 prescribing practitioner's electronic or manual signature.
8281 39
8382 (2) The requirement of Subsection (1)(a) does not apply to prescription orders dispensed for
8483 40
8584 inpatients by hospital pharmacies if the prescriber is a current member of the hospital
8685 41
8786 staff and the prescription order is on file in the patient's medical record.
8887 42
8988 (3) Unless it is for a Schedule II controlled substance, a prescription order may be
9089 43
9190 dispensed by a pharmacist or pharmacy intern upon an oral prescription of a practitioner
9291 44
9392 only if the oral prescription is promptly reduced to writing.
9493 45
9594 (4)(a) Except as provided under Subsection (4)(b), a pharmacist or pharmacy intern may
9695 46
9796 not dispense or compound any prescription of a practitioner if the prescription shows
9897 47
9998 evidence of alteration, erasure, or addition by any person other than the person
10099 48
101100 writing the prescription.
102101 49
103102 (b) A pharmacist or pharmacy intern dispensing or compounding a prescription may
104103 50
105104 alter or make additions to the prescription after receiving permission of the prescriber
106105 51
107106 and may make entries or additions on the prescription required by law or necessitated
108107 52
109108 in the compounding and dispensing procedures.
110109 53
111110 (5)(a) Each drug dispensed shall have a label securely affixed to the container indicating
112111 54
113112 the following minimum information:
114113 55
115114 (i) the name, address, and telephone number of the pharmacy;
116115 56
117116 (ii) the serial number of the prescription as assigned by the dispensing pharmacy;
118117 57
119118 (iii) the filling date of the prescription or its last dispensing date;
120119 58
121120 (iv) the name of the patient, or in the case of an animal, the name of the owner and
122121 59
123122 species of the animal;
124123 60
125124 (v) the name of the prescriber;
126125 61
127126 (vi) the directions for use, and cautionary statements, if any, which are contained in
128127 62
129128 the prescription order or are needed;
130129 63
131130 (vii) except as provided in Subsection [(7)] (8), the trade, generic, or chemical name,
132131 64
133132 amount dispensed and the strength of dosage form, but if multiple ingredient
134-- 2 - 01-23 11:03 1st Sub. (Buff) H.B. 123
135133 65
136134 products with established proprietary or nonproprietary names are prescribed,
135+- 2 - 01-07 15:45 H.B. 123
137136 66
138137 those products' names may be used; and
139138 67
140139 (viii) the beyond use date.
141140 68
142141 (b) The requirements described in Subsections (5)(a)(i) through (vi) do not apply to a
143142 69
144143 label on the container of a drug that a health care provider administers to a patient at:
145144 70
146145 (i) a pharmaceutical administration facility; or
147146 71
148147 (ii) a hospital licensed under Title 26B, Chapter 2, Part 2, Health Care Facility
149148 72
150149 Licensing and Inspection.
151150 73
152-(6)(a) A pharmacy shall use best efforts to provide an accessible prescription label,
151+(6)(a) A pharmacy shall provide to a patient an accessible prescription label, in
153152 74
154-affixed to a patient's prescription container, if a patient informs the pharmacy that the
153+accordance with Subsections (6)(b) and (c), affixed to the patient's prescription
155154 75
156-patient:
155+container, if a patient informs the pharmacy that the patient:
157156 76
158157 (i) identifies as a person who is blind, visually impaired, or otherwise unable to read a
159158 77
160159 standard prescription label; and
161160 78
162161 (ii) requests an accessible prescription label.
163162 79
164-(b) A pharmacy shall use best efforts to provide the accessible prescription label under
163+(b) A pharmacy shall provide an accessible prescription label under Subsection (6)(a):
165164 80
166-Subsection (6)(a):
165+(i) in a timely manner comparable to other patient wait times;
167166 81
168-(i) in a timely manner comparable to other patient wait times;
167+(ii) that lasts for the duration of the prescription;
169168 82
170-(ii) in large-print, braille, or auditory format, according to the needs and preferences
169+(iii) subject to Subsection (6)(c), in a format that:
171170 83
172-of the patient, and
171+(A) is appropriate to the disability and preference of the person making the request
173172 84
174-(iii) if the label is auditory, in a format compatible with the requesting patient's
173+through use of an audible, large-print, or braille label; and
175174 85
176-device designed to audibly convey the information contained on the prescription
175+(B) contains the minimum information required under Subsection (5).
177176 86
178-label.
177+(c) A pharmacy shall use its best efforts to provide a prescription label that is compatible
179178 87
179+with a patient's device designed to audibly convey the information contained on the
180+88
181+label of a prescription drug.
182+89
180183 [(6)] (7) A hospital pharmacy that dispenses a prescription drug that is packaged in a
181-88
184+90
182185 multidose container to a hospital patient may provide the drug in the multidose container
183-89
186+91
184187 to the patient when the patient is discharged from the hospital if:
185-90
188+92
186189 (a) the pharmacy receives a discharge order for the patient; and
187-91
190+93
188191 (b) the pharmacy labels the drug with the:
189-92
192+94
190193 (i) patient's name;
191-93
194+95
192195 (ii) drug's name and strength;
193-94
196+96
194197 (iii) directions for use of the drug, if applicable; and
195-95
198+97
196199 (iv) pharmacy's name and phone number.
197-96
200+98
198201 [(7)] (8) If the prescriber specifically indicates the name of the prescription product should
199-97
202+99
200203 not appear on the label, then any of the trade, generic, chemical, established proprietary,
201-98
204+- 3 - H.B. 123 01-07 15:45
205+100
202206 and established nonproprietary names and the strength of dosage form may not be
203-- 3 - 1st Sub. (Buff) H.B. 123 01-23 11:03
204-99
207+101
205208 included.
206-100
209+102
207210 [(8)] (9) Prescribers are encouraged to include on prescription labels the information
208-101
211+103
209212 described in Section 58-17b-602.5 in accordance with the provisions of that section.
210-102
213+104
211214 [(9)] (10) A pharmacy may only deliver a prescription drug to a patient or a patient's agent:
212-103
215+105
213216 (a) in person at the pharmacy; or
214-104
217+106
215218 (b) via the United States Postal Service, a licensed common carrier, or supportive
216-105
219+107
217220 personnel, if the pharmacy takes reasonable precautions to ensure the prescription
218-106
221+108
219222 drug is:
220-107
223+109
221224 (i) delivered to the patient or patient's agent; or
222-108
225+110
223226 (ii) returned to the pharmacy.
224-109
227+111
225228 Section 2. Effective Date.
226-110
227-This bill takes effect on May 7, 2026.
229+112
230+This bill takes effect on May 7, 2025.
228231 - 4 -